Total planned funding: $441,934,873
Clear active filters
USG Aggregated Agencies
2005
2006
2007
2008
2009
2010
2011
2012
2015
2016
2017
2018
Allocations
Countries/Regions
| South Africa | $43,338,285 |
| Mozambique | $42,281,982 |
| Nigeria | $37,773,092 |
| Zambia | $35,612,928 |
| Kenya | $35,435,965 |
| Tanzania | $34,424,909 |
| Uganda | $29,846,423 |
| Botswana | $17,310,178 |
| Côte d'Ivoire | $16,737,708 |
| Zimbabwe | $16,417,055 |
| Namibia | $16,316,995 |
| Ethiopia | $15,731,560 |
| Malawi | $14,832,584 |
| Haiti | $14,510,843 |
| Vietnam | $14,094,560 |
| Rwanda | $13,347,747 |
| Eswatini | $8,754,785 |
| Lesotho | $8,538,287 |
| Democratic Republic of the Congo | $7,297,349 |
| Cameroon | $6,651,825 |
| Ukraine | $5,845,284 |
| Guyana | $2,098,149 |
| South Sudan | $2,000,000 |
| Ghana | $1,748,507 |
| Burundi | $987,873 |
Organizational Types
| Own Agency | $441,934,873 |
Program Areas
| Management and Operations | $299,605,278 |
| Treatment | $48,701,219 |
| Governance and Systems | $39,923,593 |
| Care | $28,336,301 |
| Prevention | $16,233,396 |
| Testing | $9,135,086 |
Budget Codes
| HVMS: Management and Operations | $299,605,278 |
| HTXS: Treatment: Adult Treatment | $37,506,765 |
| HVSI: Strategic Information | $22,673,738 |
| HBHC: Care: Adult Care and Support | $12,341,177 |
| OHSS: Health Systems Strengthening | $10,517,178 |
| HVCT: Testing: HIV Testing and Counseling | $9,135,086 |
| PDTX: Treatment: Pediatric Treatment | $8,170,144 |
| HLAB: Laboratory Infrastructure | $6,732,677 |
| HVTB: Care: TB/HIV | $5,719,864 |
| PDCS: Care: Pediatric Care and Support | $5,251,429 |
| HVOP: Sexual Prevention: Other Sexual Prevention | $5,109,843 |
| HKID: Care: Orphans and Vulnerable Children | $5,023,831 |
| MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $4,500,977 |
| CIRC: Biomedical Prevention: Voluntary Medical Male Circumcision | $3,954,268 |
| HTXD: Treatment: ARV Drugs | $3,024,310 |
| HVAB: Sexual Prevention: Abstinence/Be Faithful | $1,159,517 |
| IDUP: Prevention: Injecting and Non-Injecting Drug Use | $891,343 |
| HMBL: Biomedical Prevention: Blood Safety | $368,051 |
| HMIN: Biomedical Prevention: Injection Safety | $249,397 |
Top Partner Programs
USG Aggregated Agencies:
$441,934,873
View countries